Trials / Unknown
UnknownNCT01012882
Efficacy and Safety of Sublingual Immunotherapy (SLIT)
A Multicenter Randomized DBPC Trial to Evaluate Efficacy and Safety of Sublingual Immunotherapy (SLIT) With Allergen Extracts From Pollen in Patients With Seasonal Allergic Rhinitis
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Roxall Medizin · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of specific sublingual immunotherapy (SLIT) with allergen extracts in patients suffering from seasonal allergic rhinitis .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | sublingual immunotherapy with allergen extract | sublingual application |
| BIOLOGICAL | sublingual immunotherapy with placebo | sublingual application |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2017-11-01
- Completion
- 2017-11-01
- First posted
- 2009-11-13
- Last updated
- 2015-11-03
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01012882. Inclusion in this directory is not an endorsement.